Abstract Number: 052 • 2026 Pediatric Rheumatology Symposium
Case Series: Treatment of Refractory Lung Disease in Systemic Juvenile Idiopathic Arthritis with Cyclophosphamide and Rituximab Combination Therapy
Background/Purpose: Systemic juvenile idiopathic arthritis-associated lung disease (sJIA-LD) is a rare, potentially fatal complication of sJIA, often accompanied by pulmonary hypertension (PH) and macrophage activation…Abstract Number: 050 • 2026 Pediatric Rheumatology Symposium
The Quiet Beginning: Early Pediatric Systemic Lupus Erythematosus (SLE) Without Nephritis and the Path to Renal Involvement
Background/Purpose: It is well known that patients with juvenile Systemic Lupus Erythematosus (jSLE) are at much higher risk of developing Lupus Nephritis (LN) compared…Abstract Number: 079 • 2026 Pediatric Rheumatology Symposium
Still’s Disease Associated Lung Disease: Update From the European Registry
Background/Purpose: Lung disease (LD) is an emerging severe life-threatening complication of Still’s Disease (SD) characterized by peculiar features. Patients with SD complicated by LD are…Abstract Number: 007 • 2026 Pediatric Rheumatology Symposium
Subtle Signs, Severe Consequences: Clinical profile of infants with giant coronary aneurysms compared to those with normal coronaries. A multicentric retrospective analysis of infants with Kawasaki disease
Background/Purpose: Kawasaki disease (KD) is a systemic medium vessel vasculitis that is predominantly a clinical diagnosis as defined by the American Heart Association (AHA). KD…Abstract Number: 082 • 2026 Pediatric Rheumatology Symposium
Ophthalmic Predictors of Response to Methotrexate Monotherapy in Pediatric Non-Infectious Uveitis
Background/Purpose: Children with chronic, non-infectious uveitis (NIU) often require systemic, steroid-sparing therapy to control inflammation and prevent vision-threatening complications. Methotrexate (MTX) is the first-line systemic…Abstract Number: 078 • 2026 Pediatric Rheumatology Symposium
Development of A High-Parameter Whole Blood Thrombo-inflammation Flow Cytometry Panel for Research in Pediatric Autoimmune Diseases
Background/Purpose: Platelets are emerging as key modulators and protagonists of aberrant immune responses in severe systemic autoimmune diseases like systemic lupus erythematosus (SLE). While the…Abstract Number: 045 • 2026 Pediatric Rheumatology Symposium
Genotypes and Clinical Phenotypes of Monogenic Autoinflammatory Disorders in Michigan
Background/Purpose: Data regarding monogenic systemic autoinflammatory disorders (SAID) from the USA is scarce. Our study aims to report the spectrum of SAID and detail unique…Abstract Number: 049 • 2026 Pediatric Rheumatology Symposium
Novel Insights of Brain MRI Features in Neonatal Lupus Erythematosus with Hydrocephalus
Background/Purpose: Neurologic manifestations in neonatal lupus erythematosus (NLE) are rare and remain poorly characterized. Macrocephaly and hydrocephalus have been reported in approximately 10% of cases,…Abstract Number: 087 • 2026 Pediatric Rheumatology Symposium
A Growing Problem: Factors Associated with Growth Disturbances in Juvenile Localized Scleroderma
Background/Purpose: Juvenile localized scleroderma (jLS) is a chronic autoimmune, fibrosing condition associated with a high burden of damage, including functional impairment. Severe morbidity most often…Abstract Number: 081 • 2026 Pediatric Rheumatology Symposium
Therapeutic Drug Monitoring in Pediatric Rheumatology: A Survey of Providers in North America
Background/Purpose: Therapeutic drug monitoring (TDM) can optimize patient outcomes in pediatric rheumatology, but its use is not standardized. This study aimed to explore TDM practice…Abstract Number: 060 • 2026 Pediatric Rheumatology Symposium
Impact of Social Determinants of Health on Outcomes in Pediatric Uveitis
Background/Purpose: Chronic uveitis is an immune-mediated disease that can cause severe complications, including blindness. Chronic uveitis care involves numerous medical visits, frequent laboratory monitoring and…Abstract Number: 071 • 2026 Pediatric Rheumatology Symposium
The Association Between Age at Diagnosis and Health-Related Quality of Life in Takayasu Arteritis
Background/Purpose: Takayasu arteritis (TAK) can occur throughout the lifespan and impacts health-related quality of life (HRQoL). This study examined the relationship between age at diagnosis…Abstract Number: 062 • 2026 Pediatric Rheumatology Symposium
Evaluating the Relationship Between an Electronic Transition Planning Tool and Transition Success in a Pediatric Rheumatology Clinic
Background/Purpose: Young adults with chronic health conditions deserve an intentional transition from pediatric to adult care. We have developed a longitudinal process to standardize transfer…Abstract Number: 024 • 2026 Pediatric Rheumatology Symposium
Therapeutic Plasma Exchange in Pediatric Autoimmune Encephalitis
Background/Purpose: Autoimmune encephalitis (AE) is a severe neuroinflammatory disorder mediated by antibodies against neuronal receptors. Therapeutic plasma exchange (TPE) can remove autoantibodies, immune complexes, and…Abstract Number: 003 • 2026 Pediatric Rheumatology Symposium
Dysregulated Macrophage–Fibroblast Crosstalk Identified by Single-Cell RNA-seq in Juvenile Systemic Scleroderma Skin
Background/Purpose: Juvenile systemic scleroderma (jSSc) is a rare autoimmune disease characterized by progressive fibrosis and vascular dysfunction. Although jSSc shares important clinical features with adult…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 2616
- Next Page »